Please try another search
Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.
Name | Age | Since | Title |
---|---|---|---|
Boaz Wachtel | 62 | 2015 | Co-Founder & Non-Executive Chairman |
William Lay | - | 2021 | Group CEO, MD & Director |
Walter P. Von Wartburg | 84 | 2019 | Member of Scientific Advisory Board |
Felix Gutzwiller | 76 | 2017 | Member of Scientific Advisory Board |
Peter Ernest Hatfull | 71 | 2022 | Non-Executive Director |
Isaac Kobrin | 77 | - | Member of Scientific Advisory Board |
Bruce A. Linton | 57 | 2020 | Independent Non-Executive Director |
Brian Walker | - | 2021 | Strategic Consultant & Chair of Scientific Advisory Committee |
Micheline MacKay | - | 2022 | Executive Director |
Ben Quirin | - | 2022 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review